Literature DB >> 15777565

Acute hepatitis C: diagnosis and management.

Mario U Mondelli1, Antonella Cerino, Agostino Cividini.   

Abstract

Mesh：

Year:  2004        PMID： 15777565     DOI： 10.1016/j.jhep.2004.10.017

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  11 in total

1.  Prospective follow-up of patients with acute hepatitis C virus infection in Brazil.

Authors:  Lia L Lewis-Ximenez; Georg M Lauer; Julian Schulze Zur Wiesch; Paulo Sergio Fonseca de Sousa; Cleber F Ginuino; Gláucia Paranhos-Baccalá; Hanno Ulmer; Karl P Pfeiffer; Georg Goebel; João Luiz Pereira; Jaqueline Mendes de Oliveira; Clara Fumiko Tachibana Yoshida; Elisabeth Lampe; Carlos Eduardo Velloso; Marcelo Alves Pinto; Henrique Sergio Coelho; Adilson José Almeida; Carlos Augusto Fernandes; Arthur Y Kim; Alexander M Strasak
Journal:  Clin Infect Dis       Date:  2010-05-01       Impact factor: 9.079

2.  Hepatitis C disease transmission and treatment uptake: impact on the cost-effectiveness of new direct-acting antiviral therapies.

Authors:  Hayley Bennett; Jason Gordon; Beverley Jones; Thomas Ward; Samantha Webster; Anupama Kalsekar; Yong Yuan; Michael Brenner; Phil McEwan
Journal:  Eur J Health Econ       Date:  2016-11-01

3.  Acute hepatitis C: prospects and challenges.

Authors:  Sanaa M Kamal
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

4.  Computed tomography findings for predicting severe acute hepatitis with prolonged cholestasis.

Authors:  Sang Jung Park; Jin Dong Kim; Yeon Seok Seo; Beom Jin Park; Min Ju Kim; Soon Ho Um; Chang Ha Kim; Hyung Joon Yim; Soon Koo Baik; Jin Yong Jung; Bora Keum; Yoon Tae Jeen; Hong Sik Lee; Hoon Jai Chun; Chang Duck Kim; Ho Sang Ryu
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

Review 5.  Modeling hepatitis C virus transmission among people who inject drugs: Assumptions, limitations and future challenges.

Authors:  Nick Scott; Margaret Hellard; Emma Sue McBryde
Journal:  Virulence       Date:  2015-08-25       Impact factor: 5.882

6.  Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections.

Authors:  Hayley Bennett; Phil McEwan; Daniel Sugrue; Anupama Kalsekar; Yong Yuan
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

Review 7.  Seronegative hepatitis C virus infection.

Authors:  Justyna Kaźmierczak; Agnieszka Pawełczyk; Kamila Caraballo Cortes; Marek Radkowski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-11-09       Impact factor: 4.291

8.  Eliminating hepatitis C virus as a public health threat among HIV-positive men who have sex with men: a multi-modelling approach to understand differences in sexual risk behaviour.

Authors:  Nick Scott; Mark Stoové; David P Wilson; Olivia Keiser; Carol El-Hayek; Joseph Doyle; Margaret Hellard
Journal:  J Int AIDS Soc       Date:  2018-01       Impact factor: 5.396

Review 9.  Epidemiology, transmission, diagnosis, and outcome of Hepatitis C virus infection.

Authors:  Seyed Hamid Moosavy; Parivash Davoodian; Mirza Ali Nazarnezhad; Abdolazim Nejatizaheh; Ebrahim Eftekhar; Hamidreza Mahboobi
Journal:  Electron Physician       Date:  2017-10-25

10.  Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits.

Authors:  Nick Scott; Thin Mar Win; Tom Tidhar; Hla Htay; Bridget Draper; Phyo Thu Zar Aung; Yinzong Xiao; Anna Bowring; Christian Kuschel; Sonjelle Shilton; Khin Pyone Kyi; Win Naing; Khin Sanda Aung; Margaret Hellard
Journal:  Lancet Reg Health West Pac       Date:  2021-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.